David A. Siegel Pfizer Inc Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Pfizer Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 16,952,600 shares of PFE stock, worth $423 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
16,952,600
Previous 17,761,700
4.56%
Holding current value
$423 Million
Previous $497 Million
1.28%
% of portfolio
1.19%
Previous 1.13%
Shares
29 transactions
Others Institutions Holding PFE
# of Institutions
3,256Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$12.9 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.24 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.08 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.25 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $140B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...